No Data
No Data
INITIATE Ventures Closes $45 Million to Fund and Co-create Companies at the Intersection of Healthcare, Life Sciences, and Tech
CGS International Adjusts Delfi's Price Target to SG$0.96 From SG$0.93, Keeps at Add
Delfi Could Face Challenges From Indonesian Market -- Market Talk
Delfi Reports Decline in Third-Quarter Sales and EBITDA
Delfi Limited's (SGX:P34) Top Owners Are Private Companies With 51% Stake, While 34% Is Held by Individual Investors
DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening
No Data
No Data